We developed a dendrimer-cysteamine conjugate formulation (PAMAM-DENCYS), and tested its ability to induce trafficking of F508del-CFTR to the PM in CF cells (Brockman et al., 2017). This evidence concerns the gene CFTR and cystic fibrosis.